Reuters :: Health

Novartis's Lescol drug protects heart after surgery

MUNICH (Reuters) - Giving patients Novartis's anti-cholesterol drug Lescol after major vascular surgery reduces the risk of serious heart problems, researchers said on Monday. <p><a href="http://feeds.reuters.com/~a/reuters/healthNews?a=yupGlS"><img src="http://feeds.reuters.com/~a/reuters/healthNews?i=yupGlS" border="0"></img></a></p><div class="feedflare"> <a href="http://feeds.reuters.com/~f/reuters/healthNews?a=jIOTUL"><img src="http://feeds.reuters.com/~f/reuters/healthNews?i=jIOTUL" border="0"></img></a> <a href="http://feeds.reuters.com/~f/reuters/healthNews?a=ItAl4l"><img src="http://feeds.reuters.com/~f/reuters/healthNews?i=ItAl4l" border="0"></img></a> <a href="http://feeds.reuters.com/~f/reuters/healthNews?a=dzJTwl"><img src="http://feeds.reuters.com/~f/reuters/healthNews?i=dzJTwl" border="0"></img></a> </div><img src="http://feeds.reuters.com/~r/reuters/healthNews/~4/380320006" height="1" width="1"/>